Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 0 | 0 |
% | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company operates as a third-party supplier of medical and healthcare devices. This is a highly competitive and fragmented segment. The sustainability of margins going forward raises concern. Based on FY22 earnings, the issue is fully priced. It has increased the IPO size with the change of Lead Manager. Considering all these, there is no harm in skipping this issue. Read detail review...
QMS Medical IPO Reviews, analysis and views by popular members. Read QMS Medical Allied Services Ltd. IPO reviews by retail investors to find recommended ipo to buy.
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 0 | 0 | 0 | 0 |
% | 0.00 | 0.00 | 0.00 | 0.00 |
Member | Review |
---|---|
No recommendation found. Be the first to post the recommendation. |
Note: